Main > A1. CORP. INDEX. Gn-Gz > Gracell Biotechnologies./P C2
Gracell Biotechnologies./P C2's subsections
2019. 04.23. Completes $85 M
2019. 06.20. Onco.>B-ALL
2023. 12.26. Acq. By AstraZeneca
2024. 02.22. Acq. By AstraZeneca
web-site
Gracell Biotechnologies./P C2's products
This section has no products